期刊文献+

肿瘤生物治疗研究进展 被引量:4

The Progress in Biotherapy of Tumor
暂未订购
导出
摘要 生物治疗是应用生物技术对各种疾病 (诸如恶性肿瘤、先天性遗传病、传染性疾病、心血管疾病、风湿免疫性疾病等 )进行治疗的一种新的治疗手段。生物治疗研究范围非常广泛 ,主要包括基因治疗、免疫治疗 (过继免疫治疗、疫苗治疗、抗体治疗、细胞因子治疗等 )、抗血管生成治疗、干细胞治疗、诱导分化及凋亡、内分泌治疗等 ,下面主要就肿瘤基因治疗。 Biotherapy is a new therapeutic tool to cure all kinds of diseases (such as malignant tumor, congenital genetic disease, infectious disease, cardiovascular disease and rheumatic disease etc. ) by biotechnology. The research scope of biotherapy is very extensive, mainly including of gene therapy, immunotherapy(adoptive immunity, vaccine, antibody and cytokine therapy etc.), anti-angiogenesis, stem cell therapy, induce differentiation and apoptosis, endocrine therapy and so on. This article explains mainly the present state and prospect in gene therapy, immunotherapy and antiangiogenic therapy for tumor.
出处 《世界科技研究与发展》 CSCD 2004年第2期1-6,共6页 World Sci-Tech R&D
关键词 生物治疗 肿瘤 基因治疗 免疫治疗 抗新生血管生成治疗 biotherapy, tumor, gene therapy, immunotherapy, antiangiogenic therapy
  • 相关文献

参考文献20

  • 1Witzig TE, et al. Randomized xontrolled trial of yttrirm-90-labeled ibritumomab tiuxitan radioimmunotherapy versus rituximab for patients with repapsed or refractory low-grade follicular or transformed B-cell non-Hodgkin' s lymphoma. J Clin Oncol, 2002,20
  • 2http://www. 863. org. cn
  • 3http://www. fda. gov
  • 4Mikala Egeblad and Zena Werb. New functions for the matrix metalloproteinases in cancer progession. Nature Review (cancer),2002,Mar(2): 161-174
  • 5Shahin Rafii. Vaccination against tumor neovascularization:Promise and reality. Cancer Cell, 2002,Dec:429-431
  • 6http://www. wiley. co. uk/genmed
  • 7Waldmann TA. Immunotherapy: past, present and future. Nat Med, 2003, 9:269
  • 8Coiffier B. Rituximab in combination with CHOPimproves survival in elderly patients with aggressive non-Hodgkin' s lymphoma. N Engl J Med, 2002, 346, 235
  • 9Frank McCormick. Cancer gene therapy fringe or cutting edge?Nature Review(cancer), 2001, Nov(1) :1-12
  • 10Jean Marx. ANGIOGENESIS: A Boost for Tumor Starvation.Science, 2003, July 25,301:452-454

同被引文献52

  • 1杜标炎,谭宇蕙,吴映雅,赵鹏,周联,赵亚刚.逆转录病毒载体介导HSV1-tk/GCV肿瘤自杀基因治疗系统的构建[J].广州中医药大学学报,2004,21(5):395-398. 被引量:10
  • 2曹蕾.癌症基因治疗新进展[J].国外医学(分子生物学分册),1994,16(5):212-215. 被引量:5
  • 3李郑武,曲洪琴,朱绿松,李会成,王晴,伞德忠.肿瘤生物治疗药物研究进展[J].中国药业,2005,14(3):75-76. 被引量:3
  • 4卢玮.肿瘤疫苗的研究[J].山西医药杂志,2005,34(5):387-388. 被引量:2
  • 5李亚荣,夏大文,唐艳,胡春梅.癌性腹水患者外周血THl、TH2细胞免疫反应状态的研究[J].激光杂志,2006,27(2):85-85. 被引量:4
  • 6Shibata M,Nezu T,Kanou H,et al.Decreased production of interleukin12 and immune responses are marked in cachectic patients with colorectal gastric cancer.J Clin Gastroenterol,2002;34(4):416-420
  • 7Yamazaki K,Yano T,Kameyama T,et al.Clinical significance of serum TH1/TH2 cytokines in patients with pulmonary adenocarcinoma.Surgery,2002;131(Suppl1):S236-S241
  • 8李宁.中晚期肝癌肝移植加局部ADV-TK基因治疗的临床研究[D].首都医科大学附属北京朝阳医院,2005年全国器官移植学术会议论文.
  • 9Mesnil M, Yamasaki H. Bystander effect in herpes simplex virusthymidine kinase/ganciclovir cancer gene therapy: role of gapjunctional intercellular communication [ Jl. Cancer Res, 2000, 60 (15): 3989.
  • 10Bonnekoh B, Greenhalgh D A, Bundman D S, et al. Adenoviral-mediatcd herpes simplex virus-thymidine kinase gene transfer in vivo for treatment of experimental human melanoma [J]. J Invest Dermatol, 1996, 106 (6) : 1163.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部